GastroPath

Click this text to start editing. This block is a basic combination of a title and a paragraph. Use it to welcome visitors to your website, or explain a product or service without using an image. Try keeping the paragraph short and breaking off the text-only areas of your page to keep your website interesting to visitors.

Click Here to Add a Title

Clinical Background

Most GI infections are common, self-limited and do not require medical attention. However, the rate of GI infection related deaths has more than doubled over the recent years and patients with persistent symptoms need to be evaluted more extensively. Conventional

gastrointestinal diagnostic techniques are variable depending on the suspected pathogen and many require rigid collection techniques and particular transport mediums to preserve the quality of the sample. In addition, the lab testing is often labor intensive and lacks the appropriate sensitivity. Unfortunately, these limitations can result in prolonged symptoms, repeated and subsequent testing and poor clinical outcomes. NCF Diagnostics & DNA Technologies offers a superior solution that eliminates these complexities so providers can efficiently and accurately treat patients.


Technology

NCF Diagnostics utilizes Real-Time PCR for pathogen identification, quantification & detection of antibiotic resistance. PCR is a molecular technique performed in a high complexity laboratory and can be used to precisely analyze the genetic material of pathogens. This advanced technology is 3-5X more sensitive than conventional culture and allows NCF to report both pathogen identification and antibiotic resistance testing results within 12-24 hours of specimen arrival at the lab.


Clinical Advantages

-Detects Polymicrobial Infections at Once

-Detects Pathogens That Can’t Be Cultured

-Provides an Accurate Diagnosis Within 24 hours

-Unaffected By Concurrent Antibiotic Use

-Decreases Additional Unnecessary Diagnostic Testing

-Ease in Specimen Collection (Swab or Stool)

-Identifies Antibiotic Resistance without Additional Testing

-Improves Antibiotic Stewardship

-Reduces Unnecessary Drug Exposure and Adverse Events

-Decreases Patient Risks

-Eliminates Subjectivity and Improves Clinical Confidence

-Improves Patient Satisfaction